administration// Blood .– 1990.–76 (suupplement 1).– P. 129a.
6.Antman KS, Griffin JD, Elias A et al., Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-indused myelosuppression// New England Journal of Medicine.– 1988.– № 319.– P. 593-598.
7.Bennett CL, Greenberg P, Gulati SC, Advani R & Bonnem E. GM-CSF decreases duration of cytopenia and hospitalization, and in-hospital costs in patients with Hodgkin’s disease treated with high-dose chemotherapy and autologous bone marrow transfusion (ABMT)// Blood.– 1990.–76 (supplement 1).– P. 132a.
8.Borden EC & Sondel PM. Lymphokines and cytokines as cancer treatment// Cancer.– 1990.– 65.– P. 800-814.
9.Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia-indused by chemotherapy in patients with small-cell lung cancer// New England Journal of Medicine.–1991.– № 325.– P. 164-170.
10.Davis I, Morstyn G. Clinical uses of growth factors// Bailliere’s Clinical Haematology.– 1992.– 5, № 3.– P. 353-377.
11.De Witte T, Gratwohl A, Van Der Lely N et al. A multicentre double blind randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in recipients of allogeneic T-cell depleted bone marrow// Blood .– 1990.–76 (supplement 1).– P. 139.
12.Dinarello CA. Interleukin-1 and interleukin-1 antagonism// Blood.– 1991.– 77.– P. 1627-1652.
13.Donahue RE, Wang EA, Stone DK et al. Stimulation of hematopoiesis in primates by continuous infusion of human GM-CSF// Nature.– 1986.– № 321.– P. 872-875.
14.Douer D, Sagi O, Shaced N, Witz IP & Ramot B. Response to recombinant murine GM-CSF in melphalan treated mice// Blood.– 1987.– 70 (supplement 1).– P. 133.
15.Dunbar CE, Smith D, Kimball J et al. Sequential treatment with recombinant human growth factors to compare activity of GM-CSF and IL3 in the treatment of primary myelodysplasia// Blood.– 1990.– 76 (supplement 1).– P. 141.
16.Dunbar CE, Smith D, Kimball J et al. Hematopoietic growth factor treatment of Diamond-Blackfan anemia// Blood.– 1990.– 76 (supplement 1).– P. 143.
17.Kawasaki ES, Ladner MB, Wang AM et al. Molecular cloning of a complementary DNA encoding human macrophage-specific colony-stimulating factor// Science.–1985.– 230.– P. 291-296.
18.Link H, Boogaerst M, Carella A et al. Recombinant human GM-CSF after autologous bone marrow transplantation for acute lymphoblastic leukemia and non-Hodgkin’s lymphoma: a randomized double blind multicenter trial in Europe// Blood.– 1990.– 76 (supplement 1).– P. 152.
19.Mayer P, Lam C, Obenaus H et al. Recombinant human GM-CSF induses leukocytosis and activates peripheral blood polymorphonuclear neutrophils in nonhuman primates// Blood.– 1987.– 70.– P. 206-213.
20.Miller CB, Platanias LC, Ratain MG et al. A phase I/II trial of erythropoietin in the treatment of chemotherapy-indused anemia// Blood.– 1990.–76 (supplement 1).– P. 156.
21.Ohno R, Tomonaga M, Kobayashi T et al. Effect of G-CSF after intensive induction therapy in relapsed of refractory acute leukemia// New England Journal of Medicine.– 1990.– 323.– P. 871-877.
22.Potter MN, Mott MG, Oakhill A. The successful tratment of a case of very severe aplastic anemia with GM-CSF and antilymphocyte globulin// British Journal of Haematology.– 1990.–75.– P. 618-619.
23.Shea TC, Mason JR, Storniolo Am et al. Beneficial effect from sequential harvesting and reinfusing of peripheral blood stem cells in conjunction with rHU GM-CSF and high dose carboplatin// Blood.– 1990.– 76 (supplement 1).–P. 165.
24. Welte K, Bonilla MA, Gillio AP et al. Recombinant human G-CSF: effects on hematopoiesis in normal and cyclophosphamide-treated primates// Journal of Experimental Medicine.–1987.–165.– P. 941-948.
25.Welte K, Zeidler C, Pietsch T et al. Correction of neutropenia in children with glycogenosis Ib by treatment with rhG-CSF// Blood.–76 (supplement 1).– P. 171.